C Scott Bailey, Theresa M Beachler, Jonathan P Mochel, Larry W Wulf, Michael Yaeger, Debosmita Kundu, Kate Withowski, Mark G Papich
{"title":"Penicillin and Gentamicin Concentrations in the Uterine Fluid of Non-Pregnant Mares Following a Single Intrauterine Infusion.","authors":"C Scott Bailey, Theresa M Beachler, Jonathan P Mochel, Larry W Wulf, Michael Yaeger, Debosmita Kundu, Kate Withowski, Mark G Papich","doi":"10.1111/jvp.13518","DOIUrl":null,"url":null,"abstract":"<p><p>Despite their widespread clinical use, there is limited pharmacokinetic data for many equine intrauterine antimicrobials. This study aimed to measure the concentration of gentamicin and penicillin in the uterine fluid of mares following infusion of either a standard (PPGent) or long-acting (LA-PPGent) compounded formulation. We hypothesized that both formulations would result in therapeutic concentrations, with total concentrations sustained for longer using the long-acting formulation. Mares were administered 2400 mg of procaine penicillin and 200 mg of gentamicin via a single intrauterine infusion in either a standard (n = 6) or a lyophilized formulation suspended in a slow-release matrix (n = 6). Intrauterine fluid was collected over a 72-h period and analyzed for antibiotic concentrations using high-performance liquid chromatography and ultra-high-performance liquid chromatography and tandem mass spectrometry. Mean maximal concentrations were seen at 0.5 h in group PPGent (Penicillin: 10,123.0 ± 4298.0 μg/mL, Gentamicin: 3397.3 ± 1338.5 μg/mL) and exceeded MIC for relevant organisms for 72 h (Penicillin: 2.59 ± 6.34 μg/mL, Gentamicin: 2.14 ± 2.4 μg/mL). Interestingly, maximal concentrations were lower in group LA-PPG (Penicillin: 2213.8 ± 967.8 μg/mL-p < 0.05, Gentamicin: 1859 ± 2413 μg/mL) and exceeded MIC for a shorter period of time than the unmodified mixture of commonly used FDA-approved antibiotics.</p>","PeriodicalId":17596,"journal":{"name":"Journal of veterinary pharmacology and therapeutics","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of veterinary pharmacology and therapeutics","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/jvp.13518","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Despite their widespread clinical use, there is limited pharmacokinetic data for many equine intrauterine antimicrobials. This study aimed to measure the concentration of gentamicin and penicillin in the uterine fluid of mares following infusion of either a standard (PPGent) or long-acting (LA-PPGent) compounded formulation. We hypothesized that both formulations would result in therapeutic concentrations, with total concentrations sustained for longer using the long-acting formulation. Mares were administered 2400 mg of procaine penicillin and 200 mg of gentamicin via a single intrauterine infusion in either a standard (n = 6) or a lyophilized formulation suspended in a slow-release matrix (n = 6). Intrauterine fluid was collected over a 72-h period and analyzed for antibiotic concentrations using high-performance liquid chromatography and ultra-high-performance liquid chromatography and tandem mass spectrometry. Mean maximal concentrations were seen at 0.5 h in group PPGent (Penicillin: 10,123.0 ± 4298.0 μg/mL, Gentamicin: 3397.3 ± 1338.5 μg/mL) and exceeded MIC for relevant organisms for 72 h (Penicillin: 2.59 ± 6.34 μg/mL, Gentamicin: 2.14 ± 2.4 μg/mL). Interestingly, maximal concentrations were lower in group LA-PPG (Penicillin: 2213.8 ± 967.8 μg/mL-p < 0.05, Gentamicin: 1859 ± 2413 μg/mL) and exceeded MIC for a shorter period of time than the unmodified mixture of commonly used FDA-approved antibiotics.
期刊介绍:
The Journal of Veterinary Pharmacology and Therapeutics (JVPT) is an international journal devoted to the publication of scientific papers in the basic and clinical aspects of veterinary pharmacology and toxicology, whether the study is in vitro, in vivo, ex vivo or in silico. The Journal is a forum for recent scientific information and developments in the discipline of veterinary pharmacology, including toxicology and therapeutics. Studies that are entirely in vitro will not be considered within the scope of JVPT unless the study has direct relevance to the use of the drug (including toxicants and feed additives) in veterinary species, or that it can be clearly demonstrated that a similar outcome would be expected in vivo. These studies should consider approved or widely used veterinary drugs and/or drugs with broad applicability to veterinary species.